Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability

Journal of the American College of Cardiology

Volumn 27, Issue 5, 1996, Pages 1083-1089

  Guo, Gary Bih Fang ^a   Ellenbogen, Kenneth A ^a   Wood, Mark A ^a   Stambler, Bruce S ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBUTILIDE FUMARATE; PLACEBO;

ACTION POTENTIAL; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FLUTTER; HUMAN; HYPOTHESIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029929528     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00607-9     Document Type: Article

References (26)

1. + current in guinea pig ventricular cells. J Pharmacol Exp Ther 1992;262:99-108.
2. Wesley RC Jr, Farkhani F, Morgan D, Zimmerman D. Ibutilide enhanced defibrillation via plateau sodium current activation. Am J Physiol 1993;264: H1269-74.
3. Stambler BS, Wood MA, Belz MK, Sperry RE, VanderLugt JT, Ellenbogen KA. Electrophysiologic determinants of pharmacologic conversion of human atrial fibrillation and flutter: enhanced efficacy of efficiency of ibutilide: a new class III antiarrhythmic drug [abstract]. Circulation 1993;88:445.
4. Ellenbogen KA, Wood MA, Stambler BS, Wakefield LK, VanderLugt JT. Conversion of atrial fibrillation and flutter by intravenous ibutilide. A multicenter dose response study [abstract]. J Am Coll Cardiol 1994;23:227A.
5. Buchanan LV, Kabel GG, Turcotte UM, Brunden MN, Gibson JK. Effects of ibutilide on spontaneous and induced ventricular arrhythmias in 24-hour canine myocardial infarction: a comparative study with sotalol and encainide. J Cardiovasc Pharmacol 1992;19:256-63.
6. Ortiz J, Igarashi M, Gonzalez HX, Laurita K, Rudy Y, Waldo AL. Mechanism of spontaneous termination of stable atrial flutter in the canine sterile pericarditis model. Circulation 1993;88:1866-77.
7. Ross DL, Farre J, Bar FWH, et al. Spontaneous termination of circus movement tachycardia utilizing an atrioventricular accessory: incidence, site of block and mechanisms. Circulation 1981;63:1129-39.
8. Vohra J, Hunt D, Stuckey J, Slomon G. Cycle length alternation in supraventricular tachycardia after administration of verapamil. Br Heart J 1974;36:570-6.
9. Wellens HJJ, Tan SL, Bar IWH, Durer DR, Lie KI, Dohmen HM. Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal reentrant supraventricular tachycardia. Br Heart J 1977;39:1048-66.
10. Duff HJ, Mitchell LB, Gillis AM, et al. Electrocardiographs correlates of spontaneous termination of ventricular tachycardia in patients with coronary artery disease. Circulation 1993;88:1054-62.
11. Callans DJ, Marchlinski FE. Characterization of spontaneous termination of sustained ventricular tachycardia associated with coronary disease. Am J Cardiol 1991;67:50-4.
12. Frame LH, Simson MB. Oscillations of conduction, action potential duration, and refractoriness. A mechanism for spontaneous termination of reentrant tachycardias. Circulation 1988;78:1277-87.
13. Frame KH, Rhee EK. Spontaneous termination of reentry after one cycle or short nonsustained runs. Role of oscillations and excess dispersion of refractoriness. Circ Res 1991;68:493-502.
14. Spinelli W, Hoffman BF. Mechanism of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents. Circ Res 1989;65: 1565-79.
15. Boyden PA, Graziano JN. Activation mapping of reentry around an anatomical barrier in the canine atrium: observations during the action of the class III agent, d-sotalol. J Cardiovasc Electrophysiol 1993;4:266-79.
16. Wu KM, Hoffman BF. Effect of procainamide and N-acetylprocainamide on atrial flutter. Studies in vivo and in vitro. Circulation 1987;76:1397-408.
17. Wells JL Jr, Maclean MAH, James TN, Waldo AL. Characteristics of atrial flutter. Studies in man after open heart surgery using fixed atrial electrodes. Circulation 1979;60:665-73.
18. Tchou PJ, Lehmann MH, Dongas J, Mahmud R, Denker ST, Akhtar M. Effects of sudden rate acceleration on the human His-Purkinje system: adaptation of refractoriness in a dampened oscillatory pattern. Circulation 1987;73:920-9.
19. Lammers WJEP, Ravelli F, Disertori M, Antolini R, Furlanello F, Allessie MA. Variation in human atrial flutter cycle length induced by ventricular beats: evidence of a reentry circuit with a partially excitable gap. J Cardiovasc Electrophysiol 1991;2:375-87.
20. Olshansky B, Wilber DJ, Hariman RJ. Atrial flutter: update on the mechanisms and treatment. PACE 1992;15:2308-35.
21. Shimizu A, Nozaki A, Rudy Y, Waldo AL. Multiplexing studies of the effects of rapid pacing on the area of slow conduction during atrial flutter in the canine pericarditis model. J Am Coll Cardiol 1991;83:983-94.
22. Ortiz J, Nozaki A, Shimizu A, Khrestian C, Rudy Y, Waldo AL. Mechanism of interruption of atrial flutter by moricizine. Electrophysiologic and multiplexing studies in the canine sterile pericarditis model of atrial flutter. Circulation 1994;89:2860-9.
23. Schoels W, Yang H, Gough WB, El-Sheriff N. Circus movement atrial flutter in the canine sterile pericarditis model. Differential effects of procainamide on the components of the reentry pathway. Circ Res 1991;68:1117-26.
24. Stambler BS, Wood MA, Ellenbogen KA. Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration: evidence of a fully excitable gap in the reentrant circuit. J Am Coll Cardiol 1996;27:453-61.
25. Inoue H, Yamshita T, Nozaki A, Sugimoto T. Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap. J Am Coll Cardiol 1991;18:1098-104.
26. Wellens HJJ. Atrial flutter: progress but no final answers. J Am Coll Cardiol 1991;17:1232-6.